Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma

Publisher： Karger

E-ISSN： 1423-0232|86|5-6|369-372

ISSN： 0030-2414

Source： Oncology, Vol.86, Iss.5-6, 2014-06, pp. : 369-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma

Oncology, Vol. 76, Iss. 3, 2009-02 ,pp. : 184-189

Karger

Access to resources Recommend Favorite

Localized BCNU chemotherapy and the multimodal management of malignant glioma

By La Rocca Renato V. Mehdorn H. Maximilian

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite

Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 330-332

Karger

Access to resources Recommend Favorite

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

By Sabel Michael Giese Alf

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3239-3257

Informa Healthcare

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin in Recurrent Malignant Glioma: Analysis of a Case Series

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 302-307

Karger

Access to resources Recommend Favorite